Even as some major global pharmaceutical majors like Novartis say India's patent laws are weak and a hurdle to their investment plans for the country
If a science graduate or a B Pharma degree was the minimum requirement for the job of medical representative some years ago, acute manpower crisis and inability to penetrate rural areas have forced the phramaceutical industry
The Allianz Group, the German financial services powerhouse, is planning to foray into the booming asset management business in India.
Besides Novartis, the other companies are Roche, J&J, Glaxo and Astrazeneca.
P B Jayakumar caught up Dr Reddy's chairman K Anji Reddy and tried to balance science and religion. And yes, there is also the question of choosing between the son and the son-in-law.
Mumbai-based pharma major Lupin will invest over Rs 200 crore (Rs 2 billion) this year to create additional manufacturing capacities.
Not too long ago, authorised generics were used by the big US-based pharmaceutical companies to thwart competition from makers of generic drugs
The Reserve Bank of India has issued a fresh directive to banks having less than the required capital to address ownership issues and take steps to increase their net worth to a minimum of Rs 300 crore (Rs 3 billion).
India topped the global chart for total amount raised through American depository receipts (ADRs) this year (January-July), beating China and Taiwan.
Atul Choksey, the former co-promoter of Asian Paints, has exited from Standard Chartered Mutual Fund.
Private equity players in India, triggered by consolidation of domestic businesses, cross-border M&As (merger and acquisitions) and split in family-owned companies, are going for big buyouts, mostly, management buyouts.
RIL is likely to take about six months to one year to estimate the oil and gas reserves available from the new discovery.
India's successful mega share offerings are creating waves globally.
Australia-based Insurance Australia Group is in advanced talks to buy a 26 per cent stake in HDFC Chubb General Insurance, following the buyout of Chubb's stake by HDFC.
Five global engineering and power equipment construction majors are in the race to bag the Rs 8,000 crore
The list, posted on a website link launched by the US regulator, includes ABB, HSBC, Nokia, Unilever, Cadbury, Total and Siemens among others.
The US Food and Drug Administration has tightened rules for selling dietary supplements in the US market, making compliance with current good manufacturing practices mandatory for manufacturers.
Indian drug major Nicholas Piramal India Ltd is likely to be among the first pharmaceutical companies worldwide to develop drugs isolated from the flora and fauna of Antarctica.
Part research being farmed out to medical colleges, universities to cut cost and time.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances